Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00851747 · ClinicalTrials.gov registry record · NA

A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal

A NA study, sponsored by The Cleveland Clinic.

Terminated
Registry status
NA
Development phase
18
Enrollment target

NCT00851747: Clinical Trial NA study, sponsored by The Cleveland Clinic.

NCT00851747 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00851747, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.

TERMINATED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

The primary objective of this study is to determine the efficacy of phosphatidylcholine and deoxycholate subcutaneous injections for localized fat removal. Subcutaneous injections of the study drug will be efficacious in decreasing localized fat deposits due to the known fat necrosis effects on fat tissue after study drug tissue incubation.

Primary Outcome

The primary objective of this study is to determine the efficacy of phosphatidylcholine and deoxycholate subcutaneous injections for localized fat removal. Subcutaneous injections of the study drug will be efficacious in decreasing localized fat deposits

Interventions

  • DRUG Saline
  • DRUG Phosphatidylcholine Deoxycholate

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2009-02
Est. Completion 2009-10
Phase NA
The Cleveland Clinic

688 total trials

Why NCT00851747 stopped before completion

NCT00851747 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.

NCT00851747 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00851747 about?

NCT00851747 is a clinical study titled "A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal". The primary objective of this study is to determine the efficacy of phosphatidylcholine and deoxycholate subcutaneous injections for localized fat removal. Subcutaneous injections of the study drug will be efficacious in decreasing localized fat deposits due to the known fat necrosis effects on fat...

What is the current status of trial NCT00851747?

This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2009-02. Estimated completion is 2009-10.

What interventions are being tested in trial NCT00851747?

The interventions under investigation include: Saline (DRUG), Phosphatidylcholine Deoxycholate (DRUG).

Who is sponsoring clinical trial NCT00851747?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

How this trial's enrollment target compares

Where NCT00851747's enrollment target sits among peer trials

18 1863rd of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00851747, the US trial registry maintained by the National Library of Medicine. NCT00851747 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.